Published in J Am Coll Nutr on June 01, 2000
Omega 3 fatty acids for prevention and treatment of cardiovascular disease. Cochrane Database Syst Rev (2004) 2.05
Beef in an Optimal Lean Diet study: effects on lipids, lipoproteins, and apolipoproteins. Am J Clin Nutr (2011) 1.62
A review of fatty acid profiles and antioxidant content in grass-fed and grain-fed beef. Nutr J (2010) 1.61
Both a traditional and modified Daniel Fast improve the cardio-metabolic profile in men and women. Lipids Health Dis (2013) 0.81
Trends in Determinants of Hypercholesterolemia among Chinese Adults between 2002 and 2012: Results from theNational Nutrition Survey. Nutrients (2017) 0.77
Transcriptomic Profiling of Spleen in Grass-Fed and Grain-Fed Angus Cattle. PLoS One (2015) 0.76
β-carotene and retinol contents in the meat of herbivorous ungulates with a special reference to their public health importance. J Vet Med Sci (2015) 0.75
A Contemporary Review of the Relationship between Red Meat Consumption and Cardiovascular Risk. Int J Prev Med (2017) 0.75
Use of robust variance components models to analyse triglyceride data in families. Ann Hum Genet (1985) 2.52
Rationale of the diet-heart statement of the American Heart Association. Report of Nutrition Committee. Circulation (1982) 2.21
Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low density (beta) lipoproteins]. Proc Natl Acad Sci U S A (1980) 2.13
Apoproteins B and A-I and coronary artery disease in humans. Arteriosclerosis (1984) 1.73
Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlled trial. JAMA (1999) 1.70
Comparison of the effects of lean red meat vs lean white meat on serum lipid levels among free-living persons with hypercholesterolemia: a long-term, randomized clinical trial. Arch Intern Med (1999) 1.57
Efficacy and safety of simvastatin 80 mg/day in hypercholesterolemic patients. The Expanded Dose Simvastatin U.S. Study Group. Am J Cardiol (1998) 1.56
Effect of gemfibrozil in men with primary isolated low high-density lipoprotein cholesterol: a randomized, double-blind, placebo-controlled, crossover study. Am J Med (1993) 1.56
Mapping a gene involved in regulating dietary cholesterol absorption. The sitosterolemia locus is found at chromosome 2p21. J Clin Invest (1998) 1.55
Association of hyperapobetalipoproteinemia with endogenous hypertriglyceridemia and atherosclerosis. Ann Intern Med (1982) 1.53
The effect of filtered-coffee consumption on plasma lipid levels. Results of a randomized clinical trial. JAMA (1992) 1.50
Familial hypercholesterolemia (one form of familial type II hyperlipoproteinemia). A study of its biochemical, genetic and clinical presentation in childhood. J Clin Invest (1974) 1.50
Maintenance of lower proportions of (n - 6) eicosanoid precursors in phospholipids of human plasma in response to added dietary (n - 3) fatty acids. Biochim Biophys Acta (1992) 1.50
Long-term predictors of subsequent cardiovascular events with coronary artery disease and 'desirable' levels of plasma total cholesterol. Circulation (1992) 1.45
Long-term effects of consuming foods containing psyllium seed husk on serum lipids in subjects with hypercholesterolemia. Am J Clin Nutr (1998) 1.44
Association between elevated plasma fibrinogen and the small, dense low-density lipoprotein phenotype among postmenopausal women. Am J Cardiol (2000) 1.44
The Bile Acid Sequestrant Acceptability scale validation study. Int J Clin Pract (2010) 1.39
Type IV hyperlipoproteinaemia. Clin Endocrinol Metab (1973) 1.38
Plasma high-density lipoproteins and ischemic heart disease: studies in a large kindred with familial hypercholesterolemia. Ann Intern Med (1978) 1.38
Neonatal diagnosis of familial type-II hyperlipoproteinaemia. Lancet (1973) 1.32
Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor. Arterioscler Thromb Vasc Biol (1995) 1.31
Long-term safety and efficacy of a cholesterol-lowering diet in children with elevated low-density lipoprotein cholesterol: seven-year results of the Dietary Intervention Study in Children (DISC). Pediatrics (2001) 1.30
Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia. JAMA (1996) 1.29
Lipid-altering efficacy and safety of simvastatin 80 mg/day: long-term experience in a large group of patients with hypercholesterolemia. World Wide Expanded Dose Simvastatin Study Group. Clin Cardiol (2000) 1.27
Dyslipidemias with desirable plasma total cholesterol levels and angiographically demonstrated coronary artery disease. Am J Cardiol (1990) 1.27
Glycolipids and other lipid constituents of normal human liver. J Lipid Res (1970) 1.26
The association of low levels of HDL cholesterol and arteriographically defined coronary artery disease. Am J Epidemiol (1979) 1.15
Fat and cholesterol intakes of white adults in Columbia, Maryland. Upper-middle socioeconomic level subjects. J Am Diet Assoc (1982) 1.13
Increased plasma cholestanol and 5 alpha-saturated plant sterol derivatives in subjects with sitosterolemia and xanthomatosis. J Lipid Res (1985) 1.11
Composition and distribution of low density lipoprotein fractions in hyperapobetalipoproteinemia, normolipidemia, and familial hypercholesterolemia. Proc Natl Acad Sci U S A (1983) 1.08
Genetic analysis of plasma sitosterol, apoprotein B, and lipoproteins in a large Amish pedigree with sitosterolemia. Am J Hum Genet (1986) 1.08
Hyperapobetalipoproteinaemia in two families with xanthomas and phytosterolaemia. Lancet (1981) 1.07
Association of plasma triglyceride concentration and LDL particle diameter, density, and chemical composition with premature coronary artery disease in men and women. J Lipid Res (1993) 1.06
Suppression of preadipocyte differentiation and promotion of adipocyte death by HIV protease inhibitors. J Biol Chem (2000) 1.06
Long-term cholesterol-lowering effects of psyllium as an adjunct to diet therapy in the treatment of hypercholesterolemia. Am J Clin Nutr (2000) 1.04
Cyclooxygenase-2 inhibition by rofecoxib reverses naturally occurring fever in humans. Clin Pharmacol Ther (1999) 1.04
The National Heart Institute Twin Study. Acta Genet Med Gemellol (Roma) (1971) 1.03
High-affinity uptake and degradation of apolipoprotein E free high-density lipoprotein and low-density lipoprotein in cultured porcine hepatocytes. Biochemistry (1982) 1.03
An HphI polymorphism in the E-selectin gene is associated with premature coronary artery disease. Clin Genet (2001) 1.01
A method for separating the granulosa cells, the basal lamina and the theca of the preovulatory ovarian follicle of the domestic fowl (Gallus domesticus). J Reprod Fertil (1977) 0.99
Effectiveness of colesevelam hydrochloride in decreasing LDL cholesterol in patients with primary hypercholesterolemia: a 24-week randomized controlled trial. Mayo Clin Proc (2001) 0.99
Predicting oxygen uptake during counterclockwise arm crank ergometry in men with lower limb disabilities. Arch Phys Med Rehabil (1995) 0.98
Hyperapobetalipoproteinemia in a kindred with familial combined hyperlipidemia and familial hypercholesterolemia. Arteriosclerosis (1987) 0.97
miniSAGE: gene expression profiling using serial analysis of gene expression from 1 microg total RNA. Anal Biochem (2000) 0.97
Efficacy and safety of combination simvastatin and colesevelam in patients with primary hypercholesterolemia. Am J Med (2001) 0.96
Influence of genetic polymorphisms on responsiveness to dietary fat and cholesterol. Am J Clin Nutr (2000) 0.96
Immunohistochemical localization of glycosphingolipid in urinary renal tubular cells in Fabry's disease. Am J Clin Pathol (1984) 0.96
Determination of high density lipoprotein-cholesterol in stored human plasma. J Lipid Res (1980) 0.95
Lipid responses to plant-sterol-enriched reduced-fat spreads incorporated into a National Cholesterol Education Program Step I diet. Am J Clin Nutr (2001) 0.95
Effects of duration of treatment and dosage of eicosapentaenoic acid and stearidonic acid on red blood cell eicosapentaenoic acid content. Prostaglandins Leukot Essent Fatty Acids (2011) 0.95
Small, dense low-density lipoprotein particles and coronary heart disease risk: A clear association with uncertain implications. JAMA (1996) 0.95
Effect of low-dose alcohol use versus abstention on apolipoproteins A-I and B. Am J Med (1988) 0.94
Simultaneous monitoring of heart rate and motion to assess energy expenditure. Med Sci Sports Exerc (1997) 0.94
Plasma dehydroepiandrosterone and dehydroepiandrosterone sulfate in patients undergoing diagnostic coronary angiography. J Am Coll Cardiol (1990) 0.93
Equivalent efficacy of a time-release form of niacin (Niaspan) given once-a-night versus plain niacin in the management of hyperlipidemia. Metabolism (1998) 0.93
Chronic consumption of rebaudioside A, a steviol glycoside, in men and women with type 2 diabetes mellitus. Food Chem Toxicol (2008) 0.93
Isolation of a porcine liver plasma membrane fraction that binds low density lipoproteins. Biochemistry (1978) 0.93
Relationship between corticosteroid exposure and plasma lipid levels in heart transplant recipients. Am J Med (1988) 0.92
Glycosphingolipids of human plasma lipoproteins. Lipids (1976) 0.91
Effects of dietary supplementation with marine lipid concentrate on the plasma lipoprotein composition of hypercholesterolemic patients. Atherosclerosis (1989) 0.91
Effects of tunicamycin on the binding and degradation of low density lipoproteins and glycoprotein synthesis in cultured human fibroblasts. J Biol Chem (1979) 0.91
Safety of a fat-reduced diet: the Dietary Intervention Study in Children (DISC). Pediatrics (1997) 0.91
DNA polymorphism haplotypes of the human lipoprotein lipase gene: possible association with high density lipoprotein levels. Hum Genet (1991) 0.90
Effects of high-dose simvastatin on adrenal and gonadal steroidogenesis in men with hypercholesterolemia. Metabolism (2000) 0.90
Genetic determination of high-density lipoprotein-cholesterol and apolipoprotein A-1 plasma levels in a family study of cardiac catheterization patients. Am J Hum Genet (1992) 0.89
Long-term blood cholesterol-lowering effects of a dietary fiber supplement. Am J Prev Med (1999) 0.89
Circulating levels of insulin-like growth factor (IGF) binding protein-1 and -3 in aging men: relationships to insulin, glucose, IGF, and dehydroepiandrosterone sulfate levels and anthropometric measures. J Clin Endocrinol Metab (1997) 0.89
The clinical, biochemical, and familial presentation of type V hyperlipoproteinemia in childhood. Pediatrics (1977) 0.89
Biochemical, clinical, epidemiologic, genetic, and pathologic data in the pediatric age group relevant to the cholesterol hypothesis. Pediatrics (1986) 0.89
Effects of continuous estrogen and estrogen-progestin replacement regimens on cardiovascular risk markers in postmenopausal women. Arch Intern Med (2000) 0.88
Safety and tolerability of esterified phytosterols administered in reduced-fat spread and salad dressing to healthy adult men and women. J Am Coll Nutr (2001) 0.88
Modulation of apolipoprotein B antigenic determinants in human low density lipoprotein subclasses. J Biol Chem (1985) 0.88
Risk factors in siblings of people with premature coronary heart disease. J Am Coll Cardiol (1988) 0.88
A low-viscosity soluble-fiber fruit juice supplement fails to lower cholesterol in hypercholesterolemic men and women. J Nutr (1998) 0.87
Plasma high-density lipoprotein cholesterol comparisons in black and white populations. The Lipid Research Clinics Program Prevalence Study. Circulation (1980) 0.87
Effects of tunicamycin on the cell-surface binding, internalization and degradation of low-density lipoproteins in human fibroblasts. Eur J Biochem (1981) 0.86
Further insights into the pathophysiology of hyperapobetalipoproteinemia: role of basic proteins I, II, III. Clin Chem (1991) 0.86
Nutrient intake and blood pressure in the Dietary Intervention Study in Children. Hypertension (1997) 0.85
Glycosphingolipids and plasma lipoproteins: a review. Can J Biochem Cell Biol (1984) 0.85
Atherosclerosis and apoproteins B and A-I. Prev Med (1983) 0.85
Stimulation of fatty acid uptake and triglyceride synthesis in human cultured skin fibroblasts and adipocytes by a serum protein. Biochem Biophys Res Commun (1987) 0.84
Effects of dietary inulin on serum lipids. J Nutr (1999) 0.83
Cholestyramine in type II hyperlipoproteinemia. A double-blind trial. Ann Intern Med (1973) 0.83
Genetic analysis of total cholesterol and triglycerides in a pedigree of St. Thomas rabbits. J Lipid Res (1989) 0.83
Efficacy and safety of lowering dietary intake of total fat, saturated fat, and cholesterol in children with elevated LDL cholesterol: the Dietary Intervention Study in Children. Am J Clin Nutr (2000) 0.83
Alterations in cell surface glycosphingolipids and other lipid classes of fibroblasts in familial hypercholesterolemia. Proc Natl Acad Sci U S A (1976) 0.83
Dose-effect relation of cholestryamine in children and young adults with familial hypercholesterolaemia. Lancet (1977) 0.82
Chitin-glucan fiber effects on oxidized low-density lipoprotein: a randomized controlled trial. Eur J Clin Nutr (2012) 0.82
Comparison of effects of simvastatin versus atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I levels. Am J Cardiol (2000) 0.81
A comparison of simvastatin and atorvastatin up to maximal recommended doses in a large multicenter randomized clinical trial. Curr Med Res Opin (2001) 0.81
Determination of high density lipoprotein-cholesterol in human plasma stored at -70 degrees C. J Lipid Res (1982) 0.81
A genetic model for control of hypertriglyceridemia and apolipoprotein B levels in the Johns Hopkins colony of St. Thomas Hospital rabbits. Genetics (1992) 0.81
Inheritance of plasma apolipoprotein B levels in families of patients undergoing coronary arteriography at an early age. Genet Epidemiol (1993) 0.81
Neonatal screening for hyperlipidemia. Pediatrics (1974) 0.81
Aerobic capacity, obesity, and atherosclerotic risk factors in male adolescents. Pediatrics (1985) 0.80
Physicians recommendations for and personal use of low-fat and low-carbohydrate diets. Int J Obes (Lond) (2005) 0.80